Diasorin Inc 1951 Northwestern Avenuestillwater Mn 55082 0285 Pma Numberp180047 Supplement Numbers014 Date Received02 04 2022 Decision Date05 05 2022 Product Code Ncd Advisory Committee Microbiology Supplement Typereal Time Process Supplement Reason Change Design Components Specifications Material Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Diasorin Inc 1951 Northwestern Avenuestillwater Mn 55082 0285 Pma Numberp180047 Supplement Numbers014 Date Received02 04 2022 Decision Date05 05 2022 Product Code Ncd Advisory Committee Microbiology Supplement Typereal Time Process Supplement Reason Change Design Components Specifications Material Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P180047S014 DiaSorin, Inc.1951 Northwestern Avenuestillwater, MN 55082-0285 PMA NumberP180047 Supplement NumberS014 Date Received02/04/2022 Decision Date05/05/2022 Product Code NCD  Advisory Committee Microbiology Supplement Typereal-time Process Supplement Reason Change Design/components/specifications/material Expedited Review Granted? No	LIAISON® QuantiFERON TB-Gold Plus assay and Control	2022-05-05